May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Diego A. Díaz García: Preventing moderate to severe dermatologic AE in 1L EGFR-mutant advanced NSCLC treatment
Mar 28, 2025, 00:13

Diego A. Díaz García: Preventing moderate to severe dermatologic AE in 1L EGFR-mutant advanced NSCLC treatment

Diego A. Díaz García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared a post on X:

“Preventing moderate to severe dermatologic AE in 1L EGFR-mutant advanced NSCLC treatment with amivantamab plus lazertinib COCOON Phase 2 trial.

COCOON DM reduced grade two or greater dermatologic AEs by 50% vs SoC DM.”